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Abstract
Background and objectives: Given that buprenorphine is a r receptor antagonist, it may also
have anti-psychotic effects. An old study of the antipsychotic effects of buprenorphine in
schizophrenia has reported positive outcomes. There are also case reports of acute psychosis after
the discontinuation of buprenorphine. The aim of this study was to determine the effect of
buprenorphine on episodes of psychosis in patients with type 1 bipolar disorder comorbid with
Lpioid dependency.
Methods: This study is a double-blind, randomized, placebo-controlled clinical trial, in which
48 patients with type I bipolar disorder and addicted to one type of opioids were treated with
buprenorphine or placebo (with other antipsychotics) for two weeks. Then the severity of
psychotic symptoms, depression and mania has been investigated.
Results: A significant improvement in psychopathology of psychosis, depression and mania
was seen in bipolar patients treated with mood stabilizers and antipsychotics with buprenorphine
or placebo. However, buprenorphine did not differ significantly in comparison with placebo. It
should be noted that buprenorphine did not show any side effects compared to placebo.
Conclusion: Buprenorphine did not show antipsychotic, antidepressant and anti-manic effects
in patients with psychotic mood episodes of type I bipolar disorder that received adequate doses
of sodium valproate and risperidone. On the other hand, this treatrnent did not show any
aggravation of psychological or mood symptoms compared to placebo.
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